Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
FDA studies show no clinically relevant reduction in oral contraceptive efficacy with semaglutide, and no backup contraception is routinely recommended
A behavioural neuroscientist by training, Sophie has spent 30 years working at the intersection of medical research, pharmacology, technology and patient communication across the pharmaceutical industry, health technology and charity sectors
The MHRA (Medicines and Healthcare products Regulatory Authority) continues to monitor the safety profile of semaglutide, including any emerging adverse effects reported by patients and healthcare professionals
Fat content: Moderate to lower fat content is generally better tolerated, as high-fat formulations may worsen nausea or delayed gastric emptying
US$ 28.40
US$ 25.83
US$ 26.81
US$ 26.77
US$ 25.34
US$ 27.95
US$ 27.14
